We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA unlawfully delayed the admission of the drug thiopental sodium, a general anesthetic used to impose capital sentences through lethal injection, the Texas Department of Criminal Justice contends. Read More
In a loss for Sanofi and Regeneron, a federal judge upheld a jury verdict validating two of Amgen’s cholesterol drug patents for Repatha, denying a request to overturn the judgment and launch a new trial. Read More
Sanofi alleges Novo Nordisk engaged in a national advertising campaign that falsely claimed access to Sanofi’s diabetes therapies Lantus and Toujeo would be restricted next year. Read More
Teva alleges six generics makers infringed a patent covering its multiple sclerosis therapy Copaxone when seeking approvals for copycat versions of the drug. Read More
Juno has filed a lawsuit against Kite Pharma for the alleged infringement of eight patent claims covering a cancer immunotherapy that uses a chimeric T cell receptor. Read More
UK’s antitrust agency has accused Actavis of breaching competition law by raising the price of generic hydrocortisone tablets for Addison’s disease by more than 12,000 percent since 2008. Read More